As filed with the Securities and Exchange Commission on May 11, 2011
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
LeMaitre Vascular, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
04-2825458
(I.R.S. Employer Identification No.)
LeMaitre Vascular, Inc.
63 Second Avenue
Burlington, Massachusetts 01803
(Address of Principal Executive Offices) (Zip Code)
Second Amended and Restated 2006 Stock Option and Incentive Plan
(Full title of the plan)
George W. LeMaitre
Chairman and Chief Executive Officer
LeMaitre Vascular, Inc.
63 Second Avenue
Burlington, Massachusetts 01803
(Name and address of agent for service)
(781) 221-2266
Telephone number, including area code, of agent for service.
Copies to:
Nicole Brookshire, Esq.
Cooley LLP
500 Boylston Street
Boston, Massachusetts 02116
(617) 937-2300
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ¨ | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ | Smaller reporting company | x |
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities To Be Registered |
Amount To Be |
Proposed Maximum Offering Price Per Share(2) |
Proposed Offering Price(2) |
Amount of Registration Fee | ||||
Common Stock, par value $0.01 per share |
1,500,000 | $5.8751 - $6.995 | $10,309,858.87 | $1,196.98 | ||||
(1) | Pursuant to Rule 416 promulgated under the Securities Act of 1933, as amended (the Securities Act), this registration statement (the Registration Statement) shall also cover any additional shares of the registrants common stock that become issuable under the above-named plan by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration that increases the number of outstanding shares of the registrants common stock. |
(2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) promulgated under the Securities Act. The offering price per share and the aggregate offering price are based (a) upon the weighted average exercise price for outstanding options granted under the registrants Second Amended and Restated 2006 Stock Option and Incentive Plan (the 2006 Stock Plan) or (b) with respect to shares reserved for future issuance under the 2006 Stock Plan, upon the average of the high and low prices of the registrants common stock as reported on The Nasdaq Global Market on May 10, 2011, in accordance with Rule 457(c) of the Securities Act. The chart below details the calculations of the registration fee: |
Title of Securities to be Registered | Number of Shares |
Offering Price Per Share (2) |
Aggregate Offering Price | |||
Common Stock, par value $0.01 per share, issuable upon the exercise of outstanding options granted under the 2006 Stock Plan |
163,087 | $5.8751(2)(a) | $958,152.43 | |||
Common Stock, par value $0.01 per share, reserved for future issuance under the 2006 Stock Plan |
1,336,913 | $6.995 (2)(b) | $9,351,706.44 | |||
Proposed Maximum Aggregate Offering Price |
$10,309,858.87 | |||||
Registration Fee |
$1,196.98 | |||||
EXPLANATORY NOTE
This Registration Statement on Form S-8 registers 1,500,000 additional shares of Common Stock, $0.01 par value per share (the Common Stock), of LeMaitre Vascular, Inc. (the Registrant) which are reserved for issuance under the Registrants Second Amended and Restated 2006 Stock Option and Incentive Plan.
INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION
STATEMENTS ON FORM S-8
The securities subject to this Registration Statement on Form S-8 are of the same class as the Registrants Common Stock for which the Registrant has previously filed Registration Statements on Form S-8 under the Securities Act. Accordingly, the contents of the Registrants Registration Statements on (i) Form S-8 (File No. 333-138181) filed with the Securities and Exchange Commission on October 24, 2006; and (ii) Form S-8 (File No. 333-161361) as filed with the Securities and Exchange Commission on August 14, 2009, are hereby incorporated by reference herein.
EXHIBITS
Exhibit No. |
Description of Exhibit | |
5.1 | Opinion of Cooley LLP. | |
23.1 | Consent of Cooley LLP (included in Exhibit 5.1 to this Registration Statement). | |
23.2 | Consent of Ernst & Young LLP. | |
24.1 | Power of Attorney (included as part of the signature page of this Registration Statement). | |
99.1(1) | Second Amended and Restated 2006 Stock Option and Incentive Plan and form of agreements thereunder. |
(1) | Previously filed as Exhibit 10.1 to the Registrants Current Report on Form 8-K (File No. 001-33092), originally filed with the SEC on June 18, 2010, and incorporated by reference herein. |
- 3 -
Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Burlington, Commonwealth of Massachusetts, on May 11, 2011.
LEMAITRE VASCULAR, INC. | ||
By: | /s/ George W. LeMaitre | |
George W. LeMaitre | ||
Chairman and Chief Executive Officer |
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL PERSONS BY THESE PRESENT, that each individual whose signature appears below hereby constitutes and appoints each of George W. LeMaitre, David B. Roberts and Aaron M. Grossman, and each or any one of them, as such persons true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such persons name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said attorney-in-fact and agent, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement and Power of Attorney has been signed by the following person in the capacities on the dates indicated.
Signature |
Title(s) |
Date | ||
/s/ George W. LeMaitre |
Chairman, Chief Executive Officer and Director | May 11, 2011 | ||
George W. LeMaitre | (Principal Executive Officer) | |||
/s/ Joseph P. Pellegrino, Jr. |
Chief Financial Officer | May 11, 2011 | ||
Joseph P. Pellegrino, Jr. | (Principal Financial Officer and Principal Accounting Officer) | |||
/s/ Russell D. Hays |
Director | May 11, 2011 | ||
Russell D. Hays | ||||
/s/ Michael C. Jackson |
Director | May 11, 2011 | ||
Michael C. Jackson | ||||
/s/ Lawrence J. Jasinski |
Director | May 11, 2011 | ||
Lawrence J. Jasinski | ||||
/s/ Cornelia W. LeMaitre |
Vice President, Human Resources and Director | May 11, 2011 | ||
Cornelia W. LeMaitre | ||||
/s/ George D. LeMaitre, M.D. |
Director | May 11, 2011 | ||
George D. LeMaitre, M.D. | ||||
/s/ John J. OConnor |
Director | May 11, 2011 | ||
John J. OConnor | ||||
/s/ David B. Roberts |
President and Director | May 11, 2011 | ||
David B. Roberts | ||||
/s/ William N. Thorndike, Jr. |
Director | May 11, 2011 | ||
William N. Thorndike, Jr. |
INDEX TO EXHIBITS
Exhibit No. |
Description of Exhibit | |
5.1 | Opinion of Cooley LLP. | |
23.1 | Consent of Cooley LLP (included in Exhibit 5.1 to this Registration Statement). | |
23.2 | Consent of Ernst & Young LLP. | |
24.1 | Power of Attorney (included as part of the signature page of this Registration Statement). | |
99.1(1) | Second Amended and Restated 2006 Stock Option and Incentive Plan and form of agreements thereunder. |
(1) | Previously filed as Exhibit 10.1 to the Registrants Current Report on Form 8-K (File No. 001-33092), originally filed with the SEC on June 18, 2010, and incorporated by reference herein. |